Toggle navigation
Home
Search
Services
Blog
Contact
About
Molecular Mechanism of Htlv-I Leukemogenesis
Lo, Kwok M.
Dana-Farber Cancer Institute, Boston, MA, United States
Search grants from Kwok Lo
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
TP10-1001, Preparedness and Emergency Response Learning Center (PERLC)
Gender Role in Trauma/Hemorrhage Induced Rbc Dysfunction
Core - Human Resources
Harvard Clinical Nutrition Research Center
Hormonal Control of Adipose Tissue Lipoprotein Lipase
Recently added grants:
Inflammasomes and Gasdermins in the Pathogenesis of Bullous Pemphigoid
Identification of the mechanism of protection against a B. burgdorferi protein CspZ for the prevention of Lyme disease
Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception
Development of a minimally invasive biomarker assay to detect delayed radiation injury
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (K11)
Project #
1K11CA001505-01
Application #
3085870
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Project Start
1990-07-01
Project End
1995-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Related projects
NIH 1991
K11 CA
Molecular Mechanism of Htlv-I Leukemogenesis
Lo, Kwok M. / Dana-Farber Cancer Institute
NIH 1990
K11 CA
Molecular Mechanism of Htlv-I Leukemogenesis
Lo, Kwok M. / Dana-Farber Cancer Institute
Comments
Be the first to comment on this grant